BlendsResearch / off-labelIMUnisex dosing

LC526

Also: Lipo-C Fat Blaster

Heaviest lipotropic, MIC + 300 mg/mL carnitine + B12 + B6 + NADH. For fat-loss-focused users on calorie restriction.

Typical dose

0.5 mL

50u, 1–2×/week

Cycle

8–12 weeks on / 2–4 off

Timing

3×/week IM, anytime

Where

IM upper outer glute

Standard

50u

0.5 mL · 1–2×/week

Half-volume vs LC120 because concentration is ~4× higher (526 mg/mL total). IM upper outer glute preferred.

Off

2–4 weeks

Reassess at 12–16 weeks for ongoing use.

Phase	How often	Dose	Units	Notes
Standard	1–2×/week	0.5 mL	50u	Half-volume vs LC120 because concentration is ~4× higher (526 mg/mL total). IM upper outer glute preferred.
Off	2–4 weeks	–	–	Reassess at 12–16 weeks for ongoing use.

Cycle & timing

Cycle: 8–12 weeks on / 2–4 off. Reassess at 16 weeks.

Timing: 3×/week IM, anytime; lidocaine reduces injection sting.

Where: IM upper outer glute. SubQ tolerable but stings at high carnitine concentration.

What to expect

Stronger fat-loss adjunct effect than LC120/LC216 over 8–12 weeks. Energy improvement within days.

Men & women

Unisex lipolytic / carnitine blend, dose by protocol; no meaningful sex difference. Avoid in pregnancy.

Recommended mixes

Vial	Water	Strength
10 ml	Solution, no reconstitution needed	L-Carnitine 300 mg/mL; Methionine 25 mg/mL; Inositol 50 mg/mL; Choline 50 mg/mL; B12 1 mg/mL; B6 50 mg/mL; NADH 50 mg/mL

10 ml: 1 unit = 3.00 mg

Storage

MixedSolution: refrigerate 36–46°F. Use within 30 days. Protect from light (NADH photodegrades).

Don't use if: Component allergies (B12, riboflavin, lecithin, choline, methionine, lidocaine) · Hypothyroid medication, separate by 4 hours · Severe hepatic impairment (choline metabolism) · Pregnancy and lactation, specific compounding required · Bleeding disorders or anticoagulants (relative), bruising risk

Side effects

Stronger garlic taste (high carnitine), flushing (B6/NADH), injection-site sting (300 mg/mL carnitine).

Drug interactions

Warfarin: L-carnitine and choline blends can potentiate, monitor INR if combining; Levothyroxine: separate by 4 hours, choline/B-vitamins affect absorption; Anticoagulants / antiplatelets (DOACs, aspirin, clopidogrel): bruising risk with phosphatidylcholine; Insulin / antidiabetics: B-complex may shift glucose, recheck log if dosing changes; Methotrexate, trimethoprim, phenytoin: deplete folate / B12; coordinate with prescriber; Lidocaine blends (LC526): avoid other caines same session, additive cardiac effects; Stimulants / phentermine: additive CV load with high-dose lipotropics, monitor BP/HR

Labs

Compound-specific: CBC + CMP baseline; no compound-specific markers routinely required; Baseline B12, folate, MMA, homocysteine (methylation markers); TSH at baseline (B12 deficiency masks hypothyroidism); Liver enzymes (choline metabolism); Hematocrit (B12 raises RBC, polycythemia risk in some)

What these labs mean →

Warnings

Compounded products, composition varies; request the pharmacy’s COA; B12 (cyanocobalamin) contains cobalt, allergy possible; Methionine elevates homocysteine in some individuals; L-Carnitine: TMAO conversion concern in CV disease (controversial, baseline lipids); Injection-site reactions common with phosphatidylcholine; Lidocaine component contraindicated in lidocaine allergy and significant cardiac conduction disease

Patient education

Fishy odor from choline/L-carnitine is normal, not allergic; Inject slowly to reduce stinging; Don’t use with warfarin without physician guidance (potentiation risk); Request exact ingredient list and concentrations from your compounder

These apply on top of the universal safety rules.